TIDMAMS
RNS Number : 2092B
Advanced Medical Solutions Grp PLC
31 May 2023
31 May 2023
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Results of Annual General Meeting
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the world-leading specialist in tissue-healing technologies ,
announces that at the Company's Annual General Meeting held today
at 11 am at the Offices of Investec Bank plc, 30 Gresham Street,
London, EC2V 7QP, all resolutions were duly passed. Further details
of each of the resolutions are set out in the Notice of Meeting,
which was sent to shareholders on 28 April 2023.
The poll results were as follows .
Resolution Title For For Against Against Total % Issued
% % Votes Capital
FINANCIAL
1 STATEMENTS 135,930,178 100.00% 2,600 0.00% 135,932,778 62.61%
-------------- ----------------- -------- -------------------- -------- ----------------- ---------
REMUNERATION
2 REPORT 134,448,331 98.78% 1,660,110 1.22% 136,108,441 62.69%
-------------- ----------------- -------- -------------------- -------- ----------------- ---------
AUDITOR
3 REMUNERATION 129,945,308 95.88% 5,579,727 4.12% 135,525,035 62.42%
-------------- ----------------- -------- -------------------- -------- ----------------- ---------
RE-ELECT P
4 ALLEN 121,131,315 88.99% 14,989,308 11.01% 136,120,623 62.70%
-------------- ----------------- -------- -------------------- -------- ----------------- ---------
RE-ELECT G
5 COOK 123,309,347 90.59% 12,804,964 9.41% 136,114,311 62.69%
-------------- ----------------- -------- -------------------- -------- ----------------- ---------
RE-ELECT D
6 LE FORT 123,977,756 91.08% 12,136,555 8.92% 136,114,311 62.69%
-------------- ----------------- -------- -------------------- -------- ----------------- ---------
ELECT L
7 SHANAHAN 136,068,717 99.97% 45,594 0.03% 136,114,311 62.69%
-------------- ----------------- -------- -------------------- -------- ----------------- ---------
RE-ELECT C
8 MEREDITH 131,687,725 96.74% 4,434,124 3.26% 136,121,849 62.70%
-------------- ----------------- -------- -------------------- -------- ----------------- ---------
RE-ELECT E
9 JOHNSON 133,113,126 97.80% 3,001,185 2.20% 136,114,311 62.69%
-------------- ----------------- -------- -------------------- -------- ----------------- ---------
FINAL
10 DIVIDEND 136,127,581 100.00% 278 0.00% 136,127,859 62.70%
-------------- ----------------- -------- -------------------- -------- ----------------- ---------
11 ALLOT SHARES* 135,448,934 99.52% 654,222 0.48% 136,103,156 62.69%
-------------- ----------------- -------- -------------------- -------- ----------------- ---------
PRE-EMPTION
12 RIGHTS* 129,949,465 95.47% 6,165,524 4.53% 136,114,989 62.69%
-------------- ----------------- -------- -------------------- -------- ----------------- ---------
PURCHASE
13 SHARES* 135,042,435 99.95% 63,012 0.05% 135,105,447 62.23%
-------------- ----------------- -------- -------------------- -------- ----------------- ---------
* Special Resolution
Notes:
1. Votes "For" and "Against" are expressed as a percentage of votes
received.
2. A "Vote withheld" is not a vote in law and is not counted in
the calculation of the votes "For" or "Against" a resolution.
3. Total number of shares in issue at close of business on 26 M
ay = 217,109,419 shares. 62.63% of the voting capital was instructed.
- Ends -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606
545508
Chris Meredith, Chief Executive Officer
Eddie Johnson, Chief Financial Officer
Michael King, Investor Relations
Consilium Strategic Communications Tel: +44 (0) 20 3709
5700
Matthew Neal / Lucy Featherstone AMS@consilium-comms.com
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597
5970
Gary Clarence / David Anderson
HSBC Bank PLC (Broker) Tel: 44 (0) 20 7991
8888
Sam McLennan / Joe Weaving / Stephanie
Cornish
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative tissue-healing technology, focused on quality outcomes
for patients and value for payers. AMS has a wide range of surgical
products including tissue adhesives, sutures, haemostats, internal
fixation devices and internal sealants, which it markets under its
brands LiquiBand(R) , RESORBA(R) , LiquiBandFix8(R) and Seal-G(R) .
AMS also supplies wound care dressings such as silver alginates,
alginates and foams through its ActivHeal(R) brand as well as under
white label. Since 2019, the Group has made five acquisitions:
Sealantis, an Israeli developer of innovative internal sealants;
Biomatlante, a French developer and manufacturer of surgical
biomaterials, Raleigh, a leading UK coater and converter of
woundcare and bio-diagnostics materials, AFS Medical, an Austrian
specialist surgical business and Connexicon, an Irish tissue
adhesives specialist.
AMS's products, manufactured in the UK, Germany, France, the
Netherlands, the Czech Republic and Israel, are sold globally via a
network of multinational or regional partners and distributors, as
well as via AMS's own direct sales forces in the UK, Austria,
Germany, the Czech Republic and Russia. The Group has R&D
innovation hubs in the UK, Ireland, Germany, France and Israel.
Established in 1991, the Group has more than 800 employees. For
more information, please see www.admedsol.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGFLFIVEVILVIV
(END) Dow Jones Newswires
May 31, 2023 09:08 ET (13:08 GMT)
Advanced Medical Solutions (AQSE:AMS.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024
Advanced Medical Solutions (AQSE:AMS.GB)
Historical Stock Chart
From Dec 2023 to Dec 2024
